Page last updated: 2024-08-23

razoxane and Sarcoma

razoxane has been researched along with Sarcoma in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19905 (38.46)18.7374
1990's4 (30.77)18.2507
2000's3 (23.08)29.6817
2010's0 (0.00)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Benjamin, RS; Minotti, G1
Gisterek, I; Mazur, G; Wróbel, T; Włodarska, I; Zymliński, R; Łacko, A1
Al-Khadimi, Z; Chow, WA; Doroshow, JH; Frankel, P; Lawrence, J; Leong, L; Lim, D; Longmate, J; Margolin, K; Morgan, RJ; Raschko, J; Shibata, S; Somlo, G; Synold, TW; Tetef, ML; Twardowski, P; Yen, Y1
Eiter, H; Rhomberg, W; Saely, CH; Schmid, F1
Liu, TF; Zhang, XF; Zhang, ZY1
Ash, A; Borden, EC; Enterline, HT; Falkson, G; Laucius, JF; Lerner, H; Paul, AR; Rosenbaum, C1
Andrich, MP; Avila, N; Balis, FM; Berg, SL; Chen, CC; Dilsizian, V; Horowitz, ME; Jarosinski, P; Poplack, DG; Venzon, D; Weaver-McClure, L; Wexler, LH1
Gefeller, D; Hassenstein, EO; Rhomberg, W1
Conti, F; Di Lauro, K; Ferraironi, A; Giannarelli, D; Lopez, M; Maini, CL; Paoletti, G; Sciuto, R; Vici, P1
Gefeller, D; Hassenstein, E; Mesche, E; Rhomberg, W1
Hellmann, K; James, SE; Jones, S; Macdonald, E; Newton, KA; Ryall, RD1
Bellet, RE; Muggia, FM; Penta, JS; Rozencweig, M; Von Hoff, DD; Wasserman, TH1
Krawczyk, J; Svoboda, VH1

Reviews

1 review(s) available for razoxane and Sarcoma

ArticleYear
[Cardiac toxicity in cancer therapy].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002, Volume: 13, Issue:73

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cardiomyopathy, Dilated; Cardiovascular Agents; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasms; Radiotherapy, Adjuvant; Razoxane; Risk Factors; Sarcoma

2002

Trials

7 trial(s) available for razoxane and Sarcoma

ArticleYear
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
    Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:3

    Topics: Adult; Antibiotics, Antineoplastic; Cardiovascular Agents; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Heart Failure; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Razoxane; Sarcoma; Sepsis; Treatment Outcome

2004
Combined vindesine and razoxane shows antimetastatic activity in advanced soft tissue sarcomas.
    Clinical & experimental metastasis, 2008, Volume: 25, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Humans; Neoplasm Metastasis; Pilot Projects; Radiotherapy; Razoxane; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Vindesine

2008
Preliminary report on AT1727 as a potential radiosensitizer.
    International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:12

    Topics: Clinical Trials as Topic; Combined Modality Therapy; Humans; Lung Neoplasms; Neoplasms; Piperazines; Radiation-Sensitizing Agents; Random Allocation; Razoxane; Sarcoma; Soft Tissue Neoplasms

1984
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cardiovascular Agents; Child; Doxorubicin; Female; Heart; Humans; Injections, Intravenous; Male; Neuroectodermal Tumors, Primitive, Peripheral; Razoxane; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Stroke Volume; Survival Rate; Transaminases

1996
Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study.
    International journal of radiation oncology, biology, physics, 1996, Dec-01, Volume: 36, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Child; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Prospective Studies; Radiation-Sensitizing Agents; Razoxane; Sarcoma; Soft Tissue Neoplasms

1996
Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Cardiovascular Agents; Drug Monitoring; Epirubicin; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Razoxane; Sarcoma; Ventricular Function, Left

1998
[Clinical experiences with radiotherapy and ICRF 159 in sarcomas].
    Strahlentherapie. Sonderbande, 1978, Volume: 75

    Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Piperazines; Radiotherapy Dosage; Random Allocation; Razoxane; Sarcoma; Soft Tissue Neoplasms

1978

Other Studies

5 other study(ies) available for razoxane and Sarcoma

ArticleYear
Doxorubicin-Dexrazoxane from Day 1 for Soft-tissue Sarcomas: The Road to Cardioprotection.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 07-15, Volume: 27, Issue:14

    Topics: Cardiotoxicity; Dexrazoxane; Doxorubicin; Humans; Razoxane; Sarcoma

2021
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas.
    American journal of clinical oncology, 1982, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Aged; Bone Neoplasms; Drug Evaluation; Female; Humans; Male; Maytansine; Mesothelioma; Middle Aged; Mitolactol; Osteosarcoma; Oxazines; Piperazines; Prognosis; Random Allocation; Razoxane; Sarcoma; Soft Tissue Neoplasms

1982
Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomas.
    Cancer, 1978, Volume: 41, Issue:1

    Topics: Adult; Aged; Female; Humans; Leukopenia; Male; Middle Aged; Piperazines; Radiotherapy, High-Energy; Razoxane; Recurrence; Remission, Spontaneous; Sarcoma; Soft Tissue Neoplasms

1978
ICRF-159: current status and clinical prospects.
    European journal of cancer, 1977, Volume: 13, Issue:11

    Topics: Alopecia; Animals; Colonic Neoplasms; Humans; Leukopenia; Lung Neoplasms; Lymphoma; Melanoma; Mice; Nausea; Neoplasms, Experimental; Piperazines; Razoxane; Rectal Neoplasms; Sarcoma

1977
Management of soft tissue sarcomas in Portsmouth 1965-1985.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1991, Volume: 3, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cobalt Radioisotopes; Combined Modality Therapy; England; Female; Humans; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, High-Energy; Razoxane; Remission Induction; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Rate

1991